Hôpital Saint-Louis is a hospital in Paris, France. It was built in 1611 by architect Claude Vellefaux at the request of Henry IV of France.

During the past decade, Hopital Saint Louis, Centre d'investigation Clinique conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Saint Louis, Centre d'investigation Clinique" are "Coronavirus" (2 trials), "Hemoglobinuria, Paroxysmal" (1 trials) and "Paroxysmal Hemoglobinuria, Nocturnal" (1 trials). Many other conditions were trialed in "Hopital Saint Louis, Centre d'investigation Clinique" in a lesser frequency.

Most popular intervention types in "Hopital Saint Louis, Centre d'investigation Clinique" are "Drug" (2 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "eculizumab" (2 trials), "2019-nCoV PCR" (1 trials), "Sequencing" (1 trials) and "Serology" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Saint Louis, Centre d'investigation Clinique" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Saint Louis, Centre d'investigation Clinique". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hopital Saint Louis, Centre d'investigation Clinique, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Saint Louis, Centre d'investigation Clinique, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".